• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine

Patent holdings for IPC class A61K 31/4375

Total number of patents in this class: 3860

10-year publication summary

186
245
231
225
242
251
275
342
304
67
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Deciphera Pharmaceuticals, LLC
238
71
Novartis AG
10450
56
Incyte Corporation
1047
52
F. Hoffmann-La Roche AG
7861
45
Immunomedics, Inc.
252
44
Merck Sharp & Dohme LLC
3726
43
Bristol-myers Squibb Company
4824
40
Merck Patent GmbH
5733
37
Bayer Pharma AG
1032
36
Boehringer Ingelheim International GmbH
4569
35
Hoffmann-La Roche Inc.
3652
34
Bayer AG
3437
30
Gilead Sciences, Inc.
2167
29
Shenzhen HighTide Biopharmaceutical, Ltd.
60
27
Pfizer Inc.
3394
26
Takeda Pharmaceutical Company Limited
2728
26
Pliant Therapeutics, Inc.
67
25
Neurocrine Biosciences, Inc.
448
24
Genentech, Inc.
4063
23
Janssen Pharmaceutica N.V.
3267
23
Other owners 3134